Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab

Andrew Chandler, Meredith K. Bartelstein, Tomohiro Fujiwara, Cristina R. Antonescu, John H. Healey, Max Vaynrub

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab'. Together they form a unique fingerprint.

Medicine & Life Sciences